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ABSTRACT
Background: Equine anesthesia morbidity and mortality rates are greater than in other domestic animals because of hypoten-
sion and hypoventilation. The important features desired in general anesthesia for horses are a rapid effect, rapid emergence 
and balanced anesthesia. The long duration of action of currently used anesthetic agents cause various complications in horses. 
The aim of the present study was to compare the clinical effects of combination of the anesthetics desflurane, detomidine and 
medetomidine in horses.
Materials, Methods & Results: Eight healthy mixed-breed horses (four males and four females) with weighing 275 ± 56 kg 
[mean ± standard deviation (SD)] and aged 6.8 ± 5 years [(mean ± SD)] were used for this study. The horses were placed into 
one of four groups: group I (detomidine-desflurane), group II (detomidine-desflurane-atipamezole), group III (medetomidine-
desflurane), or group IV (medetomidine-desflurane-atipamezole). Horses were rested for 15 days before each group starts to 
study. Intravenous detomidine (25 µg/kg) was used for premedication in groups I and II, and intravenous medetomidine (7 µg/
kg) was used for premedication in groups III and IV. Ketamine hydrocholoride (2 mg/kg) and midazolam (0.03 mg/kg) were 
intravenously administered in the same syringe to induce anesthesia. After induction of anesthesia, horses were placed in the left 
lateral recumbent position, and the trachea was intubated with a cuffed endotracheal tube with an internal diameter of 28 mm. 
The endotracheal tube was attached to a large animal circle breathing system anesthesia machine, and anesthesia was maintained 
with desflurane for 90 min. The initial dosage of desflurane was 14% + 4 L O2/min, and was reduced by 2% every 10 min over 
the first 30 min of anesthesia. After 30 min, the desflurane dose was changed to 8% + 4 L, which was maintained until the end of 
anesthesia (90 min). After 90 min, the administration of desflurane was discontinued, and all animals were supported by O2, with 
groups II and IV receiving 0.06 mg/kg atipamezole in addition to oxygen. Anaesthetic action times, hematological parameters, 
blood gas levels, electrolyte levels, biochemical values, electrocardiography values and end-tidal carbon dioxide volume were 
measured before, during, at the end of, and 24 h after anesthesia. 
Discussion: In this study, medetomidine (7 µg/kg) and detomidine (25 µg/kg) were intravenously administered, which was adequate 
and suitable for sedating horses. At the end of anesthesia, 0.06 mg/kg atipamezole was intravenously administered in groups II 
and IV. However, atipamezole did not affect the clinical parameters. Stress, excitement, fear, catecholamine exchange in blood 
circulation, hyperglycemia, and hypoxia can all cause changes in venous blood parameters. These are potential reasons for the 
changes in venous blood parameters (i.e., WBC and Hb) observed at the beginning of and during anesthesia in the present study. 
During and after the anesthetic period, serum biochemical values can be different from baseline values. They are dependent on 
the effects of anesthetic agents. During anesthesia, the decrease and increase of biochemical values stabilize the changes in the 
enzyme system that develops because of the effects of anesthetic agents. In the present study, it was considered that the changes 
in the biochemical values aimed to stabilize the changes induced by anesthesia. Regarding the electrolyte parameters evaluated 
in the study, there was a statistical difference detected in Na values between 90 min after induction of anesthesia and 24 h after 
induction of anesthesia in group IV. However,  in previous studies, the changes in Na values did not influence the cardiac pressure 
during general anesthesia. In our study, significant changes were not seen in any electrolyte parameters except Na, and atrioven-
tricular block was not detected in ECG traces. Generally, decreased ETCO2 levels are evidence of lung perfusion deficiency. It 
depends on the effects of anesthetic agents on the cardiopulmonary, cardiovascular, and respiratory systems. In particular, the 
higher pressure and dose of desflurane supress respiratory system. Oxygen supplementation in general anesthesia increases respi-
ratory rate, but a-2 agonists and ketamine-midazolam effects can eliminate the increasing respiratory rate in general anesthesia. 
Keywords: anesthesia, horse, desflurane.
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INTRODUCTION
Equine anesthesia morbidity and mortal-
ity rates are greater than in other domestic animals 
because of hypotension and hypoventilation [12]. 
Detomidine is a specific alpha_2 (a-2) adrenoreceptor 
agonist commonly used in horses [7,22]. The sedative 
and analgesic effects of detomidine depend on its 
binding to a-2 receptors in the locus coeruleus com-
plex, brain stem and spinal cord [6]. Medetomidine 
is formed by the combination of the two optical en-
ontiomers dexmedetomidine and levomedetomidine. 
It is a more potent and selective a-2 adrenoreceptor 
agonist than xylazine or detomidine [2,5,29]. Benzo-
diazepines are the most frequently used psychotropic 
drugs in animals. They act on gamma-aminobutyric 
acid (GABA) receptors located in the central nervous 
system [13,14,16]. Benzodiazepines are rarely used 
alone in horses because they cause muscle weak-
ness and ataxia [12,30]. Atipamezole is a potent and 
selective a-2 receptor blocking agent that enhances 
noradrenaline release in the central and peripheral 
nervous system. It inhibits or eliminates the effects 
of  the a-2 adrenoceptor agonists detomidine and 
medetomidine. [4,11,18]. Desflurane has the lowest 
blood-gas partition coefficient (0.42) and the highest 
minimum alveolar concentration (MAC) value (7.2 in 
horses) among inhaled anesthestic agents. It provides 
rapid induction of anesthesia, as well as rapid emer-
gence [23]. Only a small proportion of desflurane is 
metabolized in the body and it does not cause major 
toxic effect in the liver or urinary system [3]. The 
aim of the present study was to compare the clinical 
effects of combination of the anesthetics desflurane, 
detomidine and medetomidine in horses.
MATERIALS AND METHODS
Animals
Eight healthy mixed-breed horses (four males 
and four females) with weighing 275 ± 56 kg [mean ± 
standard deviation (SD)] and aged 6.8 ± 5 years [(mean 
± SD)] were used for this study. The clinical examination 
and hematological tests were done before starting the 
study. The horses were placed into one of four groups: 
group I (detomidine-desflurane), group II (detomidine-
desflurane-atipamezole), group III (medetomidine-
desflurane), or group IV (medetomidine-desflurane-
atipamezole). Horses were rested for 15 days before 
each group starts to study. All horses were fasted for 12 
h before premedication; no restriction was applied on 
water intake. Before premedication, the body weight, 
respiratory rate, body temperature, and heart rate of 
horses were recorded in examination papers.
Clinical evaluation and anesthesia
Before premedication, a 20-gauge intravenous 
catheter was placed in the right jugular vein for blood 
sample collection and administration of anesthetic 
drugs. Electrocardiography (ECG) readings, oxygen 
saturation (SpO2%), and extremity derivations (aVL, 
aVR, aVF) were measured by a BM3 Vet monitor1 
before premedication and during anesthesia. End-tidal 
carbon dioxide volume (EtCO2) was measured (Medair 
82450)2 during anaesthesia. Intravenous detomidine 
(25 µg/kg, Domosedan)3 was used for premedication 
in groups I and II, and intravenous medetomidine (7 
µg/kg, Domitor)3 was used for premedication in groups 
III and IV. Ketamine hydrocholoride (2 mg/kg, Ketasol 
10%)4 and midazolam (0.03 mg/kg, Demizolam)5 were 
intravenously administered in the same syringe to in-
duce anesthesia. After induction of anesthesia, horses 
were placed in the left lateral recumbent position, and 
the trachea was intubated with a cuffed endotracheal 
tube with an internal diameter of 28 mm. The endo-
tracheal tube was attached to a large animal circle 
breathing system anesthesia machine (Large animal 
LSD 3000 anesthetic machine)6, and anesthesia was 
maintained with desflurane (Suprane)7 for 90 min. 
The initial dosage of desflurane was 14% + 4 L O2/
min, and was reduced by 2% every 10 min over the 
first 30 min of anesthesia. After 30 min, the desflurane 
dose was changed to 8% + 4 L, which was maintained 
until the end of anesthesia (90 min). After 90 min, the 
administration of desflurane was discontinued, and 
all animals were supported by O2, with groups II and 
IV receiving 0.06 mg/kg atipamezole (Antisedan)3 in 
addition to oxygen.
After the anesthesia wore off and the palpebral 
reflex loss and returned, the spontaneous respiration, 
extubation, sternoabdominal position and standing 
up times were recorded (Table 1). ECG results, blood 
gas levels (GEM premier 3000)8, and the white blood 
count (WBC), blood pH, venous partial carbon dioxide 
(PCO2), venous partial oxygen pressure (PO2), total 
carbon dioxide (tCO2), hemoglobin level (Hb), hema-
tocrit (Ht), and serum levels of bicarbonate (HCO3-), 
electrolytes (Na+, K+, Ca++), lactate (Lac), and glucose 
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(Glu) of venous blood (MS4e)9 were evaluated before 
premedication (0 min), 15, 30, 60, and 90 min after 
induction of anesthesia, and 24 h after anesthesia (Table 
2). Levels of aspartate transaminase (AST), alanine 
transaminase (ALT), alkaline phosphatase (ALP), cre-
atine kinase MB (Ck-MB), blood urea nitrogen (BUN), 
and creatine (Cr) were evaluated before premedication, 
at the end of anesthesia (after 90 min), and 24 h after 
anesthesia (Table 3). 
Data and statistical analysis
Data were analyzed using the Shapiro-Wilk test 
for normality, then with a one- and two-way repeated 
measures ANOVA followed by Tukey or Bonferroni’s 
significant difference tests to compare intra-group and 
inter-group values. Values of P < 0.05 were considered 
statistically significant. All analyses were performed 
using IBM SPSS Statistics 21 program. Results are 
presented as the mean ± SD.
Table 1. Evaluation of anaesthetic agents actions times (mean ± SD).
Group PRLT PRRT ET SAPT SUT
G I 19 ± 5* 20 ± 9 25 ± 8 42 ± 15 58 ± 21
G II 14 ± 4 21 ± 6 21 ± 6 37 ± 14 57 ± 26
G III 11 ± 2* 21 ± 9 26 ± 5 33 ± 9 42 ± 10
G IV 15 ± 4 24 ± 3 24 ± 4 33 ± 5 40 ± 8
PRLT: Palpebral Reflex Loss Time, PRRT: Palpebral Reflex Return Time, ET: 
Extubation Time, SAPT: Sternoabdominal Position Time, SUT: Standing Up Time. 
*The significant difference between groups (P < 0.05).
Table 2. Haematological, blood gases and electrolyte values of groups (mean ± SD).
Value Group 0 min 15 min 30 min 60 min 90 min 24 h
WBC  
(mx103/
mm3)
GI 8 ± 2 A,a 8 ± 2 A,a 8 ± 1 AB,a 8 ± 1 AB,a 8 ± 1 AB,a 10 ± 2 A,a
GII 8 ± 2 A,a 9 ± 1 A,a 9 ± 1 A,a 9 ± 2 A,a 8 ± 1 A,a 10 ± 2 A,a
GIII 8 ± 1 A,ab 8 ± 1 A,ab 7 ± 1 B,ab 7 ± 1 AB,ab 7 ± 1 B,b 9 ± 3 A,a
GIV 8 ± 2 A,ab 8 ± 1 A,ab 7 ± 1 AB,ab 6 ± 2 B,b 6 ± 1 B,b 9 ± 2 A,a
Hb  
(g/dL)
GI 12 ± 1 A,a 13 ± 2 AB,a 12 ± 2 A,a 12 ± 2 A,a 11 ± 1 A,a 12 ± 1 A,a
GII 11 ± 1 A,a 13 ± 2 A,a 13 ± 1 A,a 12± 1 A,a 12 ± 2 A,a 13 ± 1 A,a
GIII 12 ± 1 A,a 11 ± 1 AB,a 12 ± 2 A,a 11 ± 1 A,a 10 ± 1 A,a 12 ± 2 A,a
GIV 11 ± 1 A,a 11 ± 1 B,a 11 ± 2 A,a 12 ± 4 A,a 10 ± 2 A,a 13 ± 2 A,a
HCO3  
(mm/L)
GI 26 ±2 A,a 25 ± 2 A,a 25 ± 3 A,a 24 ± 3 A,a 26 ± 3 A,a 27 ± 2 A,a
GII 29 ± 2 A,a 26 ± 3 A,ab 25 ± 2 A,b 25 ± 2 A,ab 26 ± 3 A,ab 28 ± 4 A,ab
GIII 29 ± 2 A,a 26 ± 2 A,a 26 ± 2 A,a 27 ± 3 A,a 27 ± 4 A,a 29 ± 2 A,a
GIV 30 ± 4 A,a 27 ± 4 A,a 26 ± 4 A,a 26 ± 4 A,a 27 ± 3 A,a 29 ± 2 A,a
tCO2
GI 27 ± 2 A,a 26 ± 2 A,a 25 ± 3 A,a 25 ± 3 A,a 25 ± 4 A,a 28 ± 2 A,a
GII 31 ± 2 A,a 27 ± 3 A,ab 26 ± 3 A,b 26 ± 2 A,b 27 ± 3 A,ab 29 ± 4 A,ab
GIII 30 ± 2 A,a 27 ± 2 A,a 27 ± 2 A,a 27 ± 3 A,a 28 ± 4 A,a 30 ± 2 A,a
GIV 31 ± 4 A,a 28 ± 4 A,a 27 ± 4 A,a 27 ± 4 A,a 28 ± 3 A,a 30 ± 2 A,a
(continues...)
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pH
GI 7,37 ± 0,5 A,b 7,40 ± 0,5 B,b 7,46 ± 0,7 B,ab 7,46 ± 0,7 B,ab 7,51 ± 0,9 AB,a 7,40 ± 0,0A,b
GII 7,38 ± 0,4 A,bc 7,45 ± 0,5 AB,ab 7,48 ± 0,6 AB,a 7,48 ± 0,4 B,a 7,50 ± 0,5 AB,a 7,37 ± 0,5A,c
GIII 7,38 ± 0,4 A,bc 7,48 ± 0,6 Aa 7,51 ± 0,9 AB,a 7,51 ± 0,8 AB,a 7,47 ± 0,7 B,ab 7,37 ± 0,5A,c
GIV 7,37 ± 0,5 A,c 7,51 ± 0,3 A,b 7,56 ± 0,5 A,ab 7,57 ± 0,5A,a 7,57 ± 0,5 A,a 7,4 ± 0,0A,c
PO2  
(mm/Hg)
GI 34 ± 3 A,a 32 ± 6 B,a 33 ± 3 A,a 40 ± 10 A,a 36 ± 8 A,a 40 ± 12A,a
GII 32 ± 7 A,a 33 ± 6 B,a 36 ± 6 A,a 41 ± 15 A,a 43 ± 13 A,a 44 ± 13A,a
GIII 33 ± 4 A,a 46 ± 12 AB,a 68 ± 53 A,a 51 ± 22 A,a 46 ± 12 A,a 33 ± 5 A,a
GIV 30 ± 3 A,b 57 ± 26 A,a 44 ± 5 A,ab 50 ± 11 A,ab 51 ± 20 A,ab 33 ± 4A,b
PCO2  
(mmHg)
GI 42 ± 2 A,a 37 ± 5 A,ab 32 ± 5 A,bc 29 ± 7 A,b 28 ± 7 A,b 40 ± 2 A,a
GII 45 ± 3 A,a 35 ± 6 A,b 30 ± 5 A,b 29 ± 3 A,b 30 ± 5 A,b 43 ± 8 A,a
GIII 45 ± 4 A,a 32 ± 5 A,b 30 ± 6 A,b 30 ± 7 A,b 32 ± 9 A,b 44 ± 3 A,a
GIV 46 ± 5 A,a 30 ± 5 A,b 27 ± 5 A,b 26 ± 5 A,b 27 ± 5 A,b 44 ± 4 A,a
O2 SAT
GI 65 ± 7 A,a 63 ± 11 B,a 70 ± 6 B,a 79 ± 12 A,a 76 ± 13 A,a 71 ± 16 A,a
GII 61 ± 14 A,a 68 ± 11 B,a 76 ± 8 B,a 78 ± 18 A,a 81 ± 15 A,a 77 ± 12 A,a
GIII 64 ± 8 A,b 84 ± 9 A,a 89 ± 8 A,a 87 ± 7 A,a 85 ± 8 A,a 65 ± 10 A,b
GIV 59 ± 5 A,b 90 ± 4 A,a 88 ± 4 A,a 90 ± 5 A,a 88 ± 9 A,a 65 ± 8 A,b
Lac 
 (mm/L)
GI 1 ± 0,2 A,c 1,5 ± 0,5 A,abc 2 ± 0,6 A,ab 2 ±1 A,a 2 ± 0,8 A,a 1 ± 0,2 A,bc
GII 1 ± 0,3 A,c 1,4 ± 0,5 A,bc 2 ± 0,4 A,ab 2 ± 0,6 A,a 2 ± 0,7 A,a 1 ± 0,6 A,bc
GIII 1 ± 0,2 A,c 1,5 ± 0,5 A,ab 2 ± 0,5 A,a 2 ± 0,6 A,a 2 ± 0,7 A,a 1 ± 0,3 A,bc
GIV 1 ± 0,2 A,c 1,2 ± 0,3 A,b 2 ± 0,5 A,a 2 ± 0,4 A,a 2 ± 0,7 A,a 1 ± 0,3 A,bc
K 
(mEq/L)
GI 3 ± 1 A,a 4 ± 1 A,a 4 ± 1 A,a 4 ± 1 A,a 4 ± 1 A,a 3 ± 1 A,a
GII 4 ± 1 A,a 4 ± 1 A,a 3 ± 0,2 A,a 4 ± 1 A,a 4 ± 1 A,a 4 ± 1 A,a
GIII 4 ± 0,3 A,a 3 ± 0,3 A,a 5 ± 5 A,a 4 ± 1 A,a 4 ± 1 A,a 3 ± 0,4 A,a
GIV 3 ± 1 A,a 3 ± 0,4 A,a 3 ± 0,2 A,a 3 ± 1 A,a 4 ± 1 A,a 3 ± 0,4 A,a
Na 
(mEq/L)
GI 142 ± 6 A,a 138 ± 6 A,a 138 ± 6 A,a 138 ± 6 A,a 139 ± 6 A,a 139 ± 6 A,a
GII 136 ± 5 A,a 136 ± 6 A,a 138 ± 5 A,a 135 ± 5 A,a 137 ± 6 A,a 140 ± 8 A,a
GIII 140 ± 3A,a 139 ± 3 A,a 137 ± 5 A,a 138 ± 3 A,a 140 ± 6 A,a 140 ± 2 A,a
GIV 139 ± 5 A,ab 138 ± 3 A,ab 137 ±3 A,ab 137 ± 5 A,ab 135 ± 3 A,b 141 ± 4 A,a
Ca 
(mmol/L)
GI 1 ± 0,3 A,a 1 ± 0,2 A,a 1 ± 0,3 A,a 1 ± 0,2 A,a 1 ± 0,2 A,a 1 ± 0,4 A,a
GII 1 ± 0,2 A,a 1 ± 0,2 A,a 1 ± 0,2 A,a 1 ± 0,2 A,a 1 ± 0,3 A,a 1 ± 0,5 A,a
GIII 1 ± 0,2 A,a 1 ± 0,2 A,a 1 ± 0,1 A,a 1 ± 0,1 A,a 1 ± 0,4 A,a 1 ± 0,2 A,a
GIV 1 ± 0,2 A,a 1 ± 0,2 A,a 1 ± 0,2 A,a 1 ± 0,2 A,a 1 ± 0,1 A,a 1 ± 0,2 A,a
(...continuation)
(continues...)
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Glu  
(mg/dl)
GI 7 3± 13 A,b 90 ± 22 A,b 115 ± 22 A,ab 152 ± 58 A,a 152 ± 62 A,a 84 ± 15 A,b
GII 75 ± 10 A,c 99 ± 27 A,bc 138 ± 33 A,ab 165 ± 26 A,a 166 ± 38 A,a 77 ± 14 A,c
GIII 68 ± 12 A,c 100 ± 22 A,abc 125 ± 36 A,ab 139 ± 50 A,a 125 ± 40 A,ab 82 ± 19 A,bc
GIV 67 ± 8 A,c 101 ± 17 A,bc 132 ± 37 A,ab 153 ± 49 A,a 139 ± 47 A,ab 72 ± 13 A,c
(...continuation)
Table 3. Biochemical values of groups (mean ± SD).
Value Group 0 min 90 min 24 h
BUN (mg/dL)
GI 45 ± 1 A,a 49 ± 8 AB,a 45 ± 10 A,a
GII 41 ± 5 A,a 40 ± 3 B,a 41 ± 3 A,a
GIII 47 ± 8 A,a 47 ± 7 AB,a 48 ± 6 A,a
GIV 47 ± 10 A,a 50 ± 9 A,a 47 ± 9 A,a
Cr (mg/dL)
GI 1,6 ± 1 A,a 2 ± 1 A,a 1,6 ± 1 A,a
GII 1 ± 1 A,a 1 ± 1 A,a 1 ± 1 A,a
GIII 1 ± 1 A,a 2 ± 1 A,a 1 ± 1 A,a
GIV 1 ± 1 A, a 1 ± 1 A,a 1 ± 1 A,a
AST (U/L)
GI 164 ± 78 A,a 176 ± 88 A,a 201 ± 88  A,a
GII 196 ± 50 A,a 177 ± 34 A,a 212 ± 40 A,a
GIII 200 ± 30 A,a 177 ± 29 A,a 205 ± 18 A,a
GIV 217 ± 30 A,a 204 ± 31 A,a 232 ± 80 A,a
ALP (IU/L)
GI 222 ± 39 A,a 228 ± 46 A,a 231 ± 54 A,a
GII 210 ± 33 A,a 184 ± 66 A,a 221 ± 40 A,a
GIII 195 ± 18 A,a 174 ± 40 A,a 205 ± 26 A,a
GIV 184 ± 19 A,a 158 ± 37 A,a 159 ± 74 A,a
Ck-MB (µg/L)
GI 3,7 ± 2 A,a 3,5 ± 3 A,a 3,5 ± 3 A,a
GII 3 ± 2 A,a 3 ± 2 A,a 3 ± 2 A,a
GIII 3 ± 1 A,a 3 ± 1 A,a 3 ± 1 A,a
GIV 3 ± 1 A,a 3 ± 1 A,a 3 ± 1 A,a
BUN: blood urea nitrogen, Cr: Creatine, AST: Aspartate Transaminase, ALP: Alkaline Phosphatase, Ck-MB: Creatine 
kinase MB, A, B, C in the same column and a, b, c in the same row are statistically significant (P < 0.05).
RESULTS
Appropriate and adequate sedation was ob-
served in all of the animals following the induction of 
anesthesia. No significant differences were observed 
in the times for loss of palpebral reflex, extubation, 
sternoabdominal position and standing up times (Table 
1). A difference was seen in the time for return of pal-
pebral reflex between groups I and III (P < 0.05); it 
was shorter in group III than in group I. Atipamezole 
did not affect these times in group II or IV.
Hematological parameters, blood gas levels, 
and electrolyte levels were measured before, during, 
at the end of, and 24 h after anesthesia; these values 
are shown in Table 2. There were significant differ-
ences found in WBC and Hb values within groups and 
between groups, but these differences were in reference 
interval. The blood pH increased in all groups during 
anesthesia, and significant differences were detected 
(P < 0.05). However, the pH returned to values within 
the normal range 24 h after anesthesia. PCO2, HCO-3, 
and tCO2 levels decreased between 15 min and 90 min 
after induction of anesthesia. The decreases in these 
values were statistically significant in all groups (P < 
0.05). The Lac levels increased between 15 min and 
90 min after induction of anesthesia in all groups. The 
increases in these values were statistically significant 
in all groups (P < 0.05). PO2 levels were different 
among groups I, II, and IV 15 min after induction of 
6                                                                                                           H. Erol & M. Arıcan. 2017. A Comparasion of Laboratory and Cardiopulmonary Effects of Desflurane, Detomidine and Medetomidine 
Anaesthetic Combinations in Horses.                                                                                                                  Acta Scientiae Veterinariae. 45: 1514.
anesthesia (P < 0.05). The highest level of PO2 was 
recorded in group IV. Na, K, and Ca levels were within 
the reference intervals during anesthesia and 24 h after 
anesthesia. Glu levels increased between 15 min and 
90 min after induction of anesthesia in all groups, and 
the increase was statistically significant (P < 0.05).
Biochemical parameters were evaluated be-
fore, at the end of, and 24 h after anesthesia (Table 
3). At 90 min after induction of anesthesia, the only 
difference observed was in the levels of BUN between 
groups II and IV (P < 0.05). No statistically significant 
differences in Cr, ALT, AST, and Ck-MB levels were 
observed within or between groups. 
Regarding cardiopulmonary findings, no sig-
nificant differences were seen in heart rate or SPO2 
levels between and among groups. Decreases in re-
spiratory rates and body temperatures were detected 
in all groups (Table 4), and these decreases were 
statistically significant (P < 0.05). The comparison 
of systolic, mean, and diastolic pressures significant 
differences were seen between and among groups. 
Blood pressure decreased between 15 min and 90 min 
during anesthesia.
Sinus bradycardia and increased T waves were 
observed in ECG tracings, but no atrioventricular 
blocks were detected.
There were no significant differences observed 
in ETCO2 levels between groups, but intra-group 
evaluation in groups II, III, and IV showed significant 
differences at 0 min and 15, 30, 60, 90 min (Table 5).
Table 4. Cardiopulmonary values of groups (mean ± SD).
Value Group 0 min 15 min 30 min 60 min 90 min 24 h
SP
GI 146 ± 74 A,a 143 ± 31 A,a 117 ± 38 A,a 124 ± 18 A,a 96 ± 27 A,a 145 ± 70 A,a
GII 148 ± 53 A,a 163 ± 53 A,a 115 ± 36 A,a 115 ± 41 A,a 125 ± 41 A,a 150 ± 48 A,a
GIII 181 ± 49 A,a 138 ± 35 A,abc 107 ± 20 A,bc 98 ± 24 A,c 102 ± 22 A,bc 153 ± 52 A,ab
GIV 190 ± 55 A,a 122 ± 23 A,bc 90 ± 17 A,c 101 ± 18 A,c 92 ± 12 A,c 174 ± 59 A,ab
DP
GI 100 ± 59 A,a 84 ± 22 A,a 73 ± 27 A,a 79 ± 19 A,a 59 ± 27 AB,a 93 ± 64 A,a
GII 88 ± 69 A,a 119 ± 70 A,a 80 ± 42 A,a 70 ± 40 AB,a 81 ± 42 A,a 106 ± 41 A,a
GIII 130 ± 49 A,a 90 ± 25 A,abc 60 ± 24 A,bc 47 ± 17 AB,c 52 ± 13 AB,c 107 ± 50 A,ab
GIV 130 ± 60 A,a 75 ± 22 A,bc 51 ± 16 A,c 46 ± 10 B,c 44 ± 12 B,c 106 ± 44 A,ab
MP
GI 116 ± 69 A,a 118 ± 34 A,a 90 ± 32 A,a 88 ± 13 A,a 74 ± 18 AB,a 120 ± 72 A,a
GII 105 ± 69 A,a 119 ± 59 A,a 88 ± 31 A,a 87 ± 47 A,a 98 ± 47 A,a 111±51 A,a
GIII 143 ± 59 A,a 107 ± 34 A,abc 77 ± 23 A,bc 64 ± 27 A,c 67 ±15 AB,bc 125 ± 58 A,ab
GIV 150 ± 55 A,a 99 ± 25 A,bc 67 ± 20 A,c 64 ± 15 A,c 58 ± 14 B,c 125 ± 47 A,ab
SP: Sistolic Pressure, DP: Diastolic Pressure, MP: Mean pressure, A, B, C in the same column and a, b, c in the same row are statistically significant 
(P < 0.05).
Table 5. ETCO2 values of groups (mean ± SD).
Value Group 0 min 15 min 30 min 60 min 90 min
 ETCO2
GI 41 ± 11 A,a 37 ± 9 A,a 34 ± 10 A,a 33 ± 8 A,a 31 ± 10 A,a
GII 41 ± 8 A,a 36 ± 8 A,ab 31 ± 9 A,ab 29 ± 10 A,b 29 ± 9 A,b
GIII 50 ± 9 A,a 38 ± 4 A,b 35 ± 3 A,b 33 ± 3 A,b 33 ± 3 A,b
GIV 50 ± 10 A,a 38 ± 7 A,b 33 ± 8 A,b 30 ± 6 A,b 28 ± 6 A,b
DISCUSSION
Numerous preanesthetic and inhaled anesthetic 
agents are used in horses, including phenothiazines, 
a-2 agonists, opioids, isoflurane, and sevoflurane 
[1,20]. Before administering anesthesic agents in 
horses, clinical and laboratory examinations should 
be performed [8,9]. In previous studies [8,28] 10 µg/
kg medetomidine was administered intravenously in 
horses as premedication, achieving heavy sedation and 
shorter time for enter preanesthesia. Arıcan et al. [1] 
intravenously administered 7 µg/kg medetomidine in 
horses, and adequate sedation was obtained. In this 
study, medetomidine (7 µg/kg) and detomidine (25 
µg/kg) were intravenously administered, which was 
adequate and suitable for sedating horses.
The times for return of palpebral reflex were 
statistically different in groups I and III; the time was 
shorter in group III than in group I. This result shows 
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that the duration of action of detomidine is longer than 
that of medetomidine. At the end of anesthesia, 0.06 
mg/kg atipamezole was intravenously administered in 
groups II and IV. However, atipamezole did not affect 
the clinical parameters of times of palpebral reflex re-
turn, sternoabdominal position and standing up times. 
Concetto et al. [4] emphasized that the atipamezole 
dose should be 5-10 times higher than the dose of an 
a-2 agonist in horses. Preanesthetic and anesthetic 
agents suppress respiration, lower the heart rate, and 
decrease organ perfusion. Thus in groups II and IV 
atipamezole exhibited prolonged binding to organ 
receptors, and did not shorten clinical parameter times.
Stress, excitement, fear, catecholamine ex-
change in blood circulation, hyperglycemia, and hy-
poxia can all cause changes in venous blood parameters 
[19]. These are potential reasons for the changes in 
venous blood parameters (i.e., WBC and Hb) observed 
at the beginning of and during anesthesia in the pres-
ent study.
The increases in venous blood pH values in all 
groups were caused by decreased levels of PO2. This 
condition was thought to be due to desflurane’s low 
blood solubility coefficient and rapid alveolar accu-
mulation, as well as its tendency to increase heart rate 
and its action as a respiratory depressant. When the pH 
changed, a decrease in PCO2 levels and an increase in 
PO2 levels were observed in all groups. Furthermore, it 
was concluded that the statistical differences of HCO3 
and tCO2 between and among groups were occurred to 
counteract respiratory alkalosis.
Alpha 2-agonists and ketamine-midazolam an-
esthetic combinations decrease PO2 levels and increase 
PCO2 levels in horses [30]. The opposite occurred 
after administration of our anesthetic combinations. 
This was because general anesthesia with oxygen 
supplementation and positive pressure on the thorax 
slowed venous circulation, decreased cardiac output, 
and alteration of PCO2 levels. After 24 h, the effects of 
the anesthetic agents wore off, and blood gas, enyzme 
and ECG values returned to normal values. In ventila-
tion assisted general anesthesia, circulating depression 
not cause to major problem in healty horses [12]. In 
our study, the horses had normal electrolyte levels and 
blood volume, and no major problems were seen. This 
is in accordance with the results of published studies. 
In animals under general anesthesia, anaerobic metabo-
lism begins to produce lactate because of decreased 
tissue perfusion; this increases the amount of lactate 
in the body during anesthesia.
Even though sympathetic stimulation and li-
polysis increase during general anesthesia in healthy 
animals, lactate produced by anaerobic metabolism 
in the muscles is balanced by decreasing adenosine 
triphosphate and creatine phosphokinase [24]. Detected 
changes in lactate levels in this study are dependent 
on this cause.
During and after the anesthetic period, serum 
biochemical values can be different from baseline 
values. They are dependent on the effects of anesthetic 
agents. During anesthesia, the decrease and increase 
of biochemical values stabilize the changes in the en-
zyme system that develops because of the effects of 
anesthetic agents [10,23]. In the present study, it was 
considered that the changes in the biochemical values 
aimed to stabilize the changes induced by anesthesia.
It was reported that desflurane causes vasodila-
tion in subcutaneous tissues, changes in heart rate and 
respiration, and decreased body temperature [17,21]. 
The decrease in body temperature of the horses was 
usually dependent on skin thickness and ambient tem-
perature 25]. The information in the literature [21,25] 
explained the changes in body temperature observed 
in our study.
The heart rate may be high before anesthesia 
in healthy horses because of psychological conditions; 
therefore, the values of the ECG results (heart rate, 
systolic pressure, mean pressure, diastolic pressure) 
may be higher than normal [15]. In our study, systolic 
pressure before anesthesia was observed to be higher 
than normal in all groups. This showed that the changes 
in heart rate during anesthesia could be due to psycho-
logical factors. Regarding the electrolyte parameters 
evaluated in the study, there was a statistical difference 
detected in Na values between 90 min after induction 
of anesthesia and 24 h after induction of anesthesia in 
group IV. However,  in previous studies, the changes 
in Na values did not influence the cardiac pressure 
during general anesthesia. In our study, significant 
changes were not seen in any electrolyte parameters 
except Na, and atrioventricular block was not detected 
in ECG traces. 
Desflurane anesthesia decreases pulmonary 
tidal volume at all MAC values. Desflurane (1 and 
1.75 MAC) decreases respiratory rate but does not 
affect heart rate or mean arterial pressure [21,26,27]. 
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In the current study, 2 MAC desflurane was initially 
administered, followed by a decrease to 1 MAC after 
30 min. The obtained data showed decreased PCO2 
levels and increased PO2 levels. These differences 
are thought to be due to the use of preanesthetics, 
ketamine-midazolam, and varying desflurane doses.
Generally, decreased ETCO2 levels are evi-
dence of lung perfusion deficiency. It depends on the 
effects of anesthetic agents on the cardiopulmonary, 
cardiovascular, and respiratory systems. In particular, 
the higher pressure and dose of desflurane supress re-
spiratory system. Oxygen supplementation in general 
anesthesia increases respiratory rate, but a-2 agonists 
and ketamine-midazolam effects can eliminate the 
increasing respiratory rate in general anesthesia. 
CONCLUSION
The anesthetic procedures and combinations 
used in this study are safe and suitable for use in horses. 
Desflurane is an ideal volatile anesthetic agent for 
horses. The results of this study suggest that desflurane 
can be used in patients with cardiovascular, liver, and 
urinary system diseases. However, caution must be 
exercised when the MAC value is exceeded, as it can 
cause negative effects on the cardiovascular system 
due to faster gas alteration of alveolar concentration.
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